All

Blog

News

Case Study

Search Article…

Blog

Converge Bio raises $25M in Series A to accelerate drug discovery with generative AI

January 13, 2026

Case Study

Indication-agnostic biomarker and target discovery across complex disease systems

January 7, 2026

Blog

When will we have the GPT moment in biology?

January 6, 2026

Blog

Solubility: The Quiet Deal-Breaker in Antibody Development

January 6, 2026

Blog

The Future of the Virtual Cell

December 30, 2025

News

Converge is recognized in most groundbreaking AI startups by Greenfield Partners and TechCrunch!

December 22, 2025

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

December 3, 2025

Case Study

Achieving a 4.5x Increase in Protein Yield with ConvergeGEO

October 23, 2025

Blog

Golden Gate Neuron in Protein Models

October 2, 2025

Blog

Are binding antibody-antigen affinity values in public datasets reproducible?

August 19, 2025

Blog

Assessing the Reproducibility of Antibody Developability Data

August 11, 2025

Blog

How reliable are public antibody-antigen datasets for model training?

July 15, 2025

Blog

A Founder’s Story of Gene Expression Optimization

May 1, 2025

Blog

Representing molecular data as "languages"

February 28, 2025

Blog

Making Open Source Work: How We Built a Practical Internal Tool

February 12, 2025

News

Converge Bio Raises $5.5M in seed round led by TLV Partners

November 20, 2024

News

converge-compugen-collaboration

Exciting Collaboration Announcement

September 26, 2024

Blog

Antibody humanization

September 25, 2024

Blog

Benchmarking AI accelerators and optimization methods

September 23, 2024

News

Converge is selected to participate in the AWS GenAI Accelerator program

September 19, 2024

Blog

The race for the first AI-discovered medications

August 21, 2024

All

Blog

News

Case Study

Blog

Converge Bio raises $25M in Series A to accelerate drug discovery with generative AI

January 13, 2026

Case Study

Indication-agnostic biomarker and target discovery across complex disease systems

January 7, 2026

Blog

When will we have the GPT moment in biology?

January 6, 2026

Blog

Solubility: The Quiet Deal-Breaker in Antibody Development

January 6, 2026

Blog

The Future of the Virtual Cell

December 30, 2025

News

Converge is recognized in most groundbreaking AI startups by Greenfield Partners and TechCrunch!

December 22, 2025

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

December 3, 2025

Case Study

Achieving a 4.5x Increase in Protein Yield with ConvergeGEO

October 23, 2025

Blog

Golden Gate Neuron in Protein Models

October 2, 2025

Blog

Are binding antibody-antigen affinity values in public datasets reproducible?

August 19, 2025

Blog

Assessing the Reproducibility of Antibody Developability Data

August 11, 2025

Blog

How reliable are public antibody-antigen datasets for model training?

July 15, 2025

Blog

A Founder’s Story of Gene Expression Optimization

May 1, 2025

Blog

Representing molecular data as "languages"

February 28, 2025

Blog

Making Open Source Work: How We Built a Practical Internal Tool

February 12, 2025

News

Converge Bio Raises $5.5M in seed round led by TLV Partners

November 20, 2024

News

converge-compugen-collaboration

Exciting Collaboration Announcement

September 26, 2024

Blog

Antibody humanization

September 25, 2024

Blog

Benchmarking AI accelerators and optimization methods

September 23, 2024

News

Converge is selected to participate in the AWS GenAI Accelerator program

September 19, 2024

Blog

The race for the first AI-discovered medications

August 21, 2024

All

Blog

News

Case Study

Search Article…

Blog

Converge Bio raises $25M in Series A to accelerate drug discovery with generative AI

January 13, 2026

Case Study

Indication-agnostic biomarker and target discovery across complex disease systems

January 7, 2026

Blog

When will we have the GPT moment in biology?

January 6, 2026

Blog

Solubility: The Quiet Deal-Breaker in Antibody Development

January 6, 2026

Blog

The Future of the Virtual Cell

December 30, 2025

News

Converge is recognized in most groundbreaking AI startups by Greenfield Partners and TechCrunch!

December 22, 2025

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

December 3, 2025

Case Study

Achieving a 4.5x Increase in Protein Yield with ConvergeGEO

October 23, 2025

Blog

Golden Gate Neuron in Protein Models

October 2, 2025

Blog

Are binding antibody-antigen affinity values in public datasets reproducible?

August 19, 2025

Blog

Assessing the Reproducibility of Antibody Developability Data

August 11, 2025

Blog

How reliable are public antibody-antigen datasets for model training?

July 15, 2025

Blog

A Founder’s Story of Gene Expression Optimization

May 1, 2025

Blog

Representing molecular data as "languages"

February 28, 2025

Blog

Making Open Source Work: How We Built a Practical Internal Tool

February 12, 2025

News

Converge Bio Raises $5.5M in seed round led by TLV Partners

November 20, 2024

News

converge-compugen-collaboration

Exciting Collaboration Announcement

September 26, 2024

Blog

Antibody humanization

September 25, 2024

Blog

Benchmarking AI accelerators and optimization methods

September 23, 2024

News

Converge is selected to participate in the AWS GenAI Accelerator program

September 19, 2024

Blog

The race for the first AI-discovered medications

August 21, 2024